v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2024   241,865        
Beginning balance at Jan. 31, 2024 $ 2,337,089 $ 121 $ 3,364,328 $ (1,058,836) $ (1,663) $ 33,139
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   416        
Issuance of common stock upon exercise of options 3,308   3,308      
Issuance of common stock under RSU and PSU release (in shares)   3,502        
Issuance of common stock under RSU and PSU release 0 $ 3 (3)      
Issuance of common stock under employee stock purchase plan (in shares)   518        
Issuance of common stock under employee stock purchase plan 56,099   56,099      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   8        
Issuance of common stock for founders holdbacks related to acquisitions 2,667   2,667      
Issuance of common stock for payment of board of director fees 261   261      
Stock-based compensation expense, net of founder revest 586,598   586,598      
Capitalized stock-based compensation 31,934   31,934      
Fair value of replacement equity awards attributable to pre-acquisition service 468   468      
Net income (loss) 76,135     73,011   3,124
Non-controlling interest 1,415         1,415
Other comprehensive income (loss) (363)       (363)  
Ending balance (in shares) at Oct. 31, 2024   246,309        
Ending balance at Oct. 31, 2024 3,095,611 $ 124 4,045,660 (985,825) (2,026) 37,678
Beginning balance (in shares) at Jul. 31, 2024   245,122        
Beginning balance at Jul. 31, 2024 2,890,590 $ 123 3,824,897 (969,003) (3,102) 37,675
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   116        
Issuance of common stock upon exercise of options 844   844      
Issuance of common stock under RSU and PSU release (in shares)   1,068        
Issuance of common stock under RSU and PSU release 0 $ 1 (1)      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   3        
Issuance of common stock for founders holdbacks related to acquisitions 889   889      
Issuance of common stock for payment of board of director fees 86   86      
Stock-based compensation expense, net of founder revest 206,489   206,489      
Capitalized stock-based compensation 12,456   12,456      
Net income (loss) (16,819)     (16,822)   3
Other comprehensive income (loss) 1,076       1,076  
Ending balance (in shares) at Oct. 31, 2024   246,309        
Ending balance at Oct. 31, 2024 3,095,611 $ 124 4,045,660 (985,825) (2,026) 37,678
Beginning balance (in shares) at Jan. 31, 2025   247,872        
Beginning balance at Jan. 31, 2025 $ 3,318,917 $ 124 4,367,070 (1,078,107) (9,593) 39,423
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares) 305 305        
Issuance of common stock upon exercise of options $ 2,628   2,628      
Issuance of common stock under RSU and PSU release (in shares)   3,583        
Issuance of common stock under RSU and PSU release 0 $ 2 (2)      
Issuance of common stock under employee stock purchase plan (in shares)   275        
Issuance of common stock under employee stock purchase plan 74,622   74,622      
Issuance of common stock for restricted stock awards (in shares)   26        
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   17        
Issuance of common stock for founders holdbacks related to acquisitions 7,670   7,670      
Issuance of common stock for payment of board of director fees 270   270      
Stock-based compensation expense, net of founder revest 817,015   817,015      
Capitalized stock-based compensation 43,245   43,245      
Fair value of replacement equity awards attributable to pre-acquisition service 2,302   2,302      
Net income (loss) (222,626)     (221,879)   (747)
Non-controlling interest 3,844         3,844
Other comprehensive income (loss) 11,130       11,130  
Ending balance (in shares) at Oct. 31, 2025   252,078        
Ending balance at Oct. 31, 2025 4,059,017 $ 126 5,314,820 (1,299,986) 1,537 42,520
Beginning balance (in shares) at Jul. 31, 2025   250,827        
Beginning balance at Jul. 31, 2025 3,794,691 $ 125 5,016,544 (1,265,989) 6,000 38,011
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   40        
Issuance of common stock upon exercise of options 273   273      
Issuance of common stock under RSU and PSU release (in shares)   1,181        
Issuance of common stock under RSU and PSU release 0 $ 1 (1)      
Issuance of common stock for restricted stock awards (in shares)   26        
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   4        
Issuance of common stock for founders holdbacks related to acquisitions 1,534   1,534      
Issuance of common stock for payment of board of director fees 94   94      
Stock-based compensation expense, net of founder revest 279,260   279,260      
Capitalized stock-based compensation 14,814   14,814      
Fair value of replacement equity awards attributable to pre-acquisition service 2,302   2,302      
Net income (loss) (33,988)     (33,997)   9
Non-controlling interest 4,500         4,500
Other comprehensive income (loss) (4,463)       (4,463)  
Ending balance (in shares) at Oct. 31, 2025   252,078        
Ending balance at Oct. 31, 2025 $ 4,059,017 $ 126 $ 5,314,820 $ (1,299,986) $ 1,537 $ 42,520